Internal Medicine, Hematology & Oncology · Riverhead, NY
NPI
1992740856
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
750 Old Country Road Building 2
Riverhead, NY, 11901
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.6M
309,881 services
Medicare patients, 2024
1,794
Average age 76
Drug cost, 2024
$12.7M
3,088 prescriptions
Company payments, 2024
$20
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander I Zuhoski was code J1439 (injection, ferric carboxymaltose, 1 mg), 119,250 times for 103 patients. In total Alexander I Zuhoski billed 309,881 services in 292 codes, and Medicare paid $4.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 119,250 | 103 | $0.88 | $104K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 22,500 | 26 | $2.23 | $50K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,600 | 28 | $44.74 | $474K |
| J1756 Injection, iron sucrose, 1 mg | Office | 9,400 | 27 | $0.18 | $1,650 |
| J0897 Injection, denosumab, 1 mg | Office | 7,320 | 55 | $20.49 | $150K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 7,040 | 17 | $37.18 | $262K |
| J2796 Injection, romiplostim, 10 micrograms | Office | 6,612 | 25 | $76.94 | $509K |
| 36415 Venipuncture Blood Collection | Office | 4,818 | 1,510 | $8.64 | $42K |
| 85025 Blood Count | Office | 4,761 | 1,418 | $7.61 | $36K |
| 88185 Surgical Pathology Examination | Office | 4,170 | 157 | $22.13 | $92K |
| 80053 Clinical Chemistry | Office | 3,856 | 1,333 | $10.34 | $40K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,819 | 121 | $0.09 | $336 |
| 99214 Office E&M - Established | Office | 2,574 | 933 | $108.46 | $279K |
| 82784 Immunoassay | Office | 2,130 | 326 | $9.11 | $19K |
| 83615 Clinical Chemistry | Office | 1,973 | 877 | $5.92 | $12K |
By year: 2022 $7.9M for 557,585 services; 2023 $6.3M for 467,203 services; 2024 $4.6M for 309,881 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 4,818 | 1,510 | $8.64 | $42K |
| 85025 Blood Count | 4,761 | 1,418 | $7.61 | $36K |
| 88185 Surgical Pathology Examination | 4,170 | 157 | $22.13 | $92K |
| 80053 Clinical Chemistry | 3,856 | 1,333 | $10.34 | $40K |
| 82784 Immunoassay | 2,130 | 326 | $9.11 | $19K |
| 83615 Clinical Chemistry | 1,973 | 877 | $5.92 | $12K |
| 84100 Clinical Chemistry | 1,882 | 850 | $4.64 | $8,739 |
| 83735 Clinical Chemistry | 1,752 | 790 | $6.56 | $11K |
| 84550 Clinical Chemistry | 1,693 | 787 | $4.43 | $7,497 |
| 82728 Clinical Chemistry | 1,528 | 754 | $13.33 | $20K |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander I Zuhoski prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 354 prescriptions and refills. In total Alexander I Zuhoski wrote 3,088 Medicare prescriptions that cost $12.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 354 | 354 | 68 | $1.3M |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 162 | 167 | 18 | $1.5M |
| Eliquis Apixaban | 135 | 194 | 29 | $111K |
| Procrit Epoetin Alfa | 107 | 107 | 14 | $301K |
| Prednisone Generic | 84 | 108 | 22 | $385 |
| Acyclovir Generic | 76 | 102 | 13 | $874 |
| Akynzeo Fosnetupitant/Palonosetron | 72 | 72 | 16 | $65K |
| Gabapentin Generic | 62 | 79 | 26 | $707 |
| Imbruvica Ibrutinib | 56 | 58 | Under 11 | $901K |
| Xtandi Enzalutamide | 51 | 51 | Under 11 | $725K |
| Hydroxyurea Generic | 50 | 91 | 15 | $1,310 |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $802K |
| Pantoprazole Sodium Generic | 44 | 94 | 13 | $613 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 44 | 44 | Under 11 | $489K |
| Xgeva Denosumab | 43 | 43 | Under 11 | $133K |
Brand drugs: 1,755 claims; generic drugs: 1,333 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Alexander I Zuhoski $20 ($20 in general payments such as food, travel and fees) from 1 company. The largest payer was CSL Behring with $20.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 1 | $20 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.